All compounds
Growth hormone and secretagoguesClinical-stage compound

MK-677 / Ibutamoren

An oral non-peptide ghrelin-receptor agonist and growth-hormone secretagogue that has undergone clinical study without receiving general approval.

Reference reviewed 5 September 2026 · No dosing or protocol information
01

What the name refers to

An oral non-peptide ghrelin-receptor agonist and growth-hormone secretagogue that has undergone clinical study without receiving general approval.

02

Evidence and regulatory context

Human clinical research exists, but this entry is not a broadly authorised consumer medicine. Trial results apply to the studied formulation, population and endpoints—not automatically to products sold online.

03

Reading product records

The record should distinguish a regulated medicine from a research-labelled analogue and state the exact molecule. For injectables, identity and quantity do not replace sterility, endotoxin, storage and batch-traceability information.

04

Primary research links

Use current regulator and study records rather than treating a catalogue description as medical evidence.